Document is current
Any future updates will be listed below
-
Authors
Vives-Usano, Marta
Hernandez-Ferrer, Carles
Maitre, Léa
Ruiz-Arenas, Carlos
Andrusaityte, Sandra
Borràs, Eva
Carracedo, Ángel
Casas, Maribel
Chatzi, Leda
Coen, Muireann
Estivill, Xavier
González, Juan R.
Grazuleviciene, Regina
Gutzkow, Kristine B.
Keun, Hector C.
Lau, Chung-Ho E.
Cadiou, Solène
Lepeule, Johanna
Mason, Dan
Quintela, Inés
Robinson, Oliver
Sabidó, Eduard
Santorelli, Gillian
Schwarze, Per E.
Siskos, Alexandros P.
Slama, Rémy
Vafeiadi, Marina
Martí, Eulàlia
Vrijheid, Martine
Bustamante, Mariona http://orcid.org/0000-0003-0127-2860
-
Funding
Funding for this research was provided by:
European Community’s Seventh Framework Programme (308333)
- License Information
-
More Information
Article History
Received: 7 February 2020
Accepted: 29 June 2020
First Online: 19 August 2020
Ethics approval and consent to participate
: The six HELIX cohorts have the required permissions by national ethics committees for their cohort recruitment and follow-up visits and for secondary use of pre-existing samples and data. The work in HELIX was covered by new ethics approvals in each country. At enrolment in the HELIX project, families were asked to sign an informed consent form for the specific HELIX work including clinical examination and biospecimen collection and analysis. An Ethics Task Force was established to support the HELIX project on ethical issues, for advice on the project’s ethical compliance, identification, and alerting to changes in legislation where applicable. Specific procedures are in place within HELIX to safeguard the privacy of study subjects and confidentiality of data [].
: No personal data is published. Families signed a consent form to participate in the study (see above).
: The authors declare that they have no competing interests.
